Summary
GlycoMimetics
Founded in 2003
Description
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. GlycoMimetics is a late clinical stage biotechnology company discovering and developing glycobiology based therapies for cancers...
Strengths
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
Weaknesses
- GlycoMimetics has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Since GlycoMimetics was founded, the company has experienced slower revenue growth than the industry average
Annual Revenue
GlycoMimetics's annual revenue
$104000
Based on Kona Equity data
-
Revenue per employee
$2000
-
Annual revenue growth since founding
$170052
-
Revenue growth rate from first known quarter to current
396.3%
Employee Count
52 employees
-
Employee growth rate from first known quarter to current
25.0%
Executives
John Magnani
Chief Science Officer
j**@glycomimetics.comBruce Johnson
Senior Vice President & Chief Commercial Officer
b**@glycomimetics.comEdwin Rock
Chief Medical Officer
e**@glycomimetics.comChristian Dinneen-Long
Vice President
c**@glycomimetics.comDeepak Tiwari
Vice President, Technical Operations
d**@glycomimetics.comCatrina Leak
Director, Clinical Supplies
c**@glycomimetics.comStephanie Irish
Senior Director, Financial Reporting
s**@glycomimetics.comDavid Entin
Contracts Director, Corporate
d**@glycomimetics.comNancye Bonomo
Project Manager, Clinical
n**@glycomimetics.comGwen Fisher
Director, Pharmacovigilance
g**@glycomimetics.comMargot Mongold
Vice President, Human Resources
m**@glycomimetics.comHenry Flanner
Vice President, Technical Operations
h**@glycomimetics.comMartina Gomes
Senior Director, Clinical Programs
m**@glycomimetics.comJoshua Arroyo
Manager, Quality System
j**@glycomimetics.comScott Shapot
Director, Regulatory Affairs
s**@glycomimetics.comJennifer Mcgeehan
Project Manager, Clinical
j**@glycomimetics.comJay Lozier
Senior Medical Director, Clinical Development
j**@glycomimetics.comDamaris Arroyo
Manager, Quality System
d**@glycomimetics.comBrian Hahn
Chief Financial Officer
b**@glycomimetics.comJohn Peterson
Vice President, Medicinal Chemistry
j**@glycomimetics.comMartina Hemmer
Senior Director, Clinical Programs
m**@glycomimetics.comBrian Olatubosun
Analytical Development Chemist III
b**@glycomimetics.comShanti Rodriguez
Clinical Development Operations Specialist & To Administrator & Thackaray Doctor
s**@glycomimetics.comJason Gmyrek
Director, Quality Assurance
j**@glycomimetics.comNathanael Stocke
Director, Formulation & Nonclinical Development
n**@glycomimetics.comSedi Burton
Director, QC & Analytical Devt
s**@glycomimetics.comDaniel Chen
Director, CMC, Technology Operations
d**@glycomimetics.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Concert Pharmaceuticals Inc
concertpharma.com- Founded in 2006
- Location: Lexington, Massachusetts
- Annual Revenue: $32.6M
- Employees: 64
- Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates. The company operates through the development of pharmaceutical products on its own behalf or in collaboration with others. Their product candida...
Cabaletta Bio, Inc.
cabalettabio.com- Founded in 2017
- Location: Philadelphia, PA
- Annual Revenue: $11.4M
- Employees: 56
- Cabaletta Bio discovers and develops targeted cell therapy product candidates to potentially cure patients with autoimmune diseases. Learn about our CAAR T cell products.
Frequency Therapeutics Inc
frequencytx.com- Founded in 2015
- Location: Woburn, MA
- Annual Revenue: $9.4M
- Employees: 72
- Frequency Therapeutics is a clinical stage biotechnology company focused on developing therapeutics that activate a persons innate regenerative potential to restore function and reverse the debilitating impact of degenerative diseases.
Oncternal Therapeutics Inc
oncternal.com- Founded in 2008
- Location: San Diego, CA
- Annual Revenue: $4.3M
- Employees: 26
- Oncternal Therapeutics is a clinical stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Our scientific approach focuses on promising, yet untapped biological pathways implicated in cancer ge...
Calithera Biosciences Inc
calithera.com- Founded in 2010
- Location: South San Francisco, CA
- Annual Revenue: $9.8M
- Employees: 63
- Calithera is developing first-in-class small molecule drugs directed against tumor metabolism and tumor immunology targets to treat cancer.
Cortexyme, Inc.
cortexyme.com- Founded in 2012
- Location: South San Francisco, CA
- Annual Revenue: $18.6M
- Employees: 55
- Cortexyme is developing novel treatments for altering the course of Alzheimer's and other degenerative diseases.
Key Information
- Name: GlycoMimetics
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 28; 283
- NAICS: 32541; 325412
See similar companies
-
By City Rockville Small Biotechnology Company in Rockville Mid-size Biotechnology Company in Rockville Pharmaceuticals in Rockville Small Pharmaceuticals in Rockville Mid-size Pharmaceuticals in Rockville
-
By State MD Small companies in MD Pharmaceuticals in MD Small Pharmaceuticals in MD Mid-size Pharmaceuticals in MD Small Biotechnology Company in MD Mid-size Biotechnology Company in MD
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 2 Founded in 2003 SIC: 28 SIC: 283 NAICS: 32541 NAICS: 325412 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare
Frequently Asked Questions
GlycoMimetics's headquarters are located at 9708 Medical Center Dr Rockville, MD 20850.
GlycoMimetics's official website is glycomimetics.com
GlycoMimetics's annual revenue is $104.0 K.
GlycoMimetics's SIC: 28; 283
GlycoMimetics's NAICS: 32541; 325412.
GlycoMimetics has 52 employees
GlycoMimetics is in the industry of Pharmaceuticals.
